中国食品药品监管Issue(8)：32-37,6.DOI:10.3969/j.issn.1673-5390.2023.08.005
化学药品创新药Ⅲ期临床试验前会议的药学共性问题及审评考虑
Pharmaceutical Common Issues and Evaluation Considerations in Pre-phase Ⅲ Clinical Trial Meetings for Innovative Chemical Drugs
摘要
关键词
创新药/Ⅲ期临床试验/药学共性问题/技术要求Key words
innovative drugs/phase Ⅲ clinical trial/pharmaceutical common issues/technical requirements分类
医药卫生引用本文复制引用
徐立华,周浩辉,赵一飞,王亚敏..化学药品创新药Ⅲ期临床试验前会议的药学共性问题及审评考虑[J].中国食品药品监管,2023,(8):32-37,6.
